TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
China Traditional Chinese Medicine Holdings Co ( (HK:0570) ) has issued an update.
China Traditional Chinese Medicine Holdings Co. Limited has entered into a New Financial Services (2025) Framework Agreement with Sinopharm Group Finance, effective from November 19, 2025, to December 31, 2025. This agreement, which includes deposit, loan, and other financial services, is designed to continue the financial relationship between the two entities. The agreement’s terms are similar to a previous arrangement set to expire, and it ensures that financial services are provided on favorable terms without requiring additional security from the company. The announcement highlights the company’s strategic financial planning and its implications for maintaining operational stability and compliance with listing rules.
The most recent analyst rating on (HK:0570) stock is a Sell with a HK$1.60 price target. To see the full list of analyst forecasts on China Traditional Chinese Medicine Holdings Co stock, see the HK:0570 Stock Forecast page.
More about China Traditional Chinese Medicine Holdings Co
China Traditional Chinese Medicine Holdings Co. Limited operates in the healthcare industry, focusing on the production and distribution of traditional Chinese medicine products. The company is a significant player in the market, leveraging its extensive network and expertise in traditional medicine to cater to a wide range of health needs.
Average Trading Volume: 40,305,492
Technical Sentiment Signal: Sell
Current Market Cap: HK$11.83B
Learn more about 0570 stock on TipRanks’ Stock Analysis page.

